• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1型神经纤维瘤病中的恶性外周神经鞘瘤:MRI支持恶性丛状神经纤维瘤的诊断。

Malignant peripheral nerve sheath tumours in neurofibromatosis type 1: MRI supports the diagnosis of malignant plexiform neurofibroma.

作者信息

Mautner V F, Friedrich R E, von Deimling A, Hagel C, Korf B, Knöfel M T, Wenzel R, Fünsterer C

机构信息

Department of Neurology, Klinikum Nord Hamburg, Langenhorner Chaussee 560, 22419 Hamburg, Germany.

出版信息

Neuroradiology. 2003 Sep;45(9):618-25. doi: 10.1007/s00234-003-0964-6. Epub 2003 Jul 24.

DOI:10.1007/s00234-003-0964-6
PMID:12898075
Abstract

Plexiform neurofibroma (PNF) is a typical feature of neurofibromatosis 1 (NF1). About 10% of patients with NF1 develop malignant peripheral nerve-sheath tumours (MPNST), usually arising from PNF, and this is the major cause of poor survival. A better prognosis can be achieved if the tumours are diagnosed at an early stage. Our objective was to establish MRI criteria for MPNST and to test their usefulness in detecting early malignant change in PNF. MRI was performed on 50 patients with NF1 and nerve-sheath tumours, of whom seven had atypical pain, tumour growth or neurological deficits indicative of malignancy; the other 43 were asymptomatic. On MRI all seven symptomatic patients had inhomogeneous lesions, due to necrosis and haemorrhage and patchy contrast enhancement. In one patient, the multiplicity of confluent tumours with inhomogeneous areas in addition to central lesions did not allow exclusion of malignancy. Only three of the 43 asymptomatic patients had comparable changes; the other 40 patients had tumours being of relatively homogeneous structure on T1- and T2-weighted images before and after contrast enhancement. All three asymptomatic patients with inhomogeneous lesions were shown to have MPNST.

摘要

丛状神经纤维瘤(PNF)是神经纤维瘤病1型(NF1)的典型特征。约10%的NF1患者会发生恶性外周神经鞘瘤(MPNST),通常由PNF发展而来,这是导致生存率低的主要原因。如果肿瘤能早期诊断,则可获得更好的预后。我们的目的是建立MPNST的MRI标准,并测试其在检测PNF早期恶性变化中的效用。对50例患有NF1和神经鞘瘤的患者进行了MRI检查,其中7例有提示恶性的非典型疼痛、肿瘤生长或神经功能缺损;其他43例无症状。在MRI上,所有7例有症状的患者均有不均匀病变,原因是坏死、出血及斑片状对比增强。1例患者,除中央病变外,融合性肿瘤的多样性及不均匀区域无法排除恶性。43例无症状患者中只有3例有类似变化;其他40例患者的肿瘤在对比增强前后的T1加权和T2加权图像上结构相对均匀。所有3例有不均匀病变的无症状患者均被证实患有MPNST。

相似文献

1
Malignant peripheral nerve sheath tumours in neurofibromatosis type 1: MRI supports the diagnosis of malignant plexiform neurofibroma.1型神经纤维瘤病中的恶性外周神经鞘瘤:MRI支持恶性丛状神经纤维瘤的诊断。
Neuroradiology. 2003 Sep;45(9):618-25. doi: 10.1007/s00234-003-0964-6. Epub 2003 Jul 24.
2
Malignant peripheral nerve sheath tumors (MPNST) in neurofibromatosis type 1 (NF1): diagnostic findings on magnetic resonance images and mutation analysis of the NF1 gene.1型神经纤维瘤病(NF1)中的恶性外周神经鞘瘤(MPNST):磁共振成像的诊断结果及NF1基因的突变分析
Anticancer Res. 2005 May-Jun;25(3A):1699-702.
3
Clinical relevance of positron emission tomography and magnetic resonance imaging in the progression of internal plexiform neurofibroma in NF1.正电子发射断层扫描和磁共振成像在1型神经纤维瘤病内部丛状神经纤维瘤进展中的临床相关性
Anticancer Res. 2007 Jul-Aug;27(4A):1819-22.
4
Evaluation of (18)fluorodeoxyglucose positron emission tomography ((18)FDG PET) in the detection of malignant peripheral nerve sheath tumours arising from within plexiform neurofibromas in neurofibromatosis 1.18氟脱氧葡萄糖正电子发射断层扫描((18)FDG PET)在检测神经纤维瘤病1型丛状神经纤维瘤内发生的恶性外周神经鞘瘤中的应用评估
J Neurol Neurosurg Psychiatry. 2000 Mar;68(3):353-7. doi: 10.1136/jnnp.68.3.353.
5
[18F]2-fluoro-2-deoxy-D-glucose positron emission tomography (FDG PET) as a diagnostic tool for neurofibromatosis 1 (NF1) associated malignant peripheral nerve sheath tumours (MPNSTs): a long-term clinical study.[18F]2-氟-2-脱氧-D-葡萄糖正电子发射断层扫描(FDG PET)作为1型神经纤维瘤病(NF1)相关恶性外周神经鞘瘤(MPNST)的诊断工具:一项长期临床研究
Ann Oncol. 2008 Feb;19(2):390-4. doi: 10.1093/annonc/mdm450. Epub 2007 Oct 11.
6
Limitations and benefits of FDG-PET/CT in NF1 patients with nerve sheath tumors: A cross-sectional/longitudinal study.神经纤维瘤病 1 型患者神经鞘瘤中 18F-FDG PET/CT 的局限性和优势:一项横断面/纵向研究。
Cancer Sci. 2021 Mar;112(3):1114-1122. doi: 10.1111/cas.14802. Epub 2021 Jan 22.
7
Diffusion-Weighted Magnetic Resonance Imaging Improves the Accuracy of Differentiation of Benign from Malignant Peripheral Nerve Sheath Tumors.弥散加权磁共振成像提高了良性与恶性外周神经鞘瘤的鉴别准确率。
World Neurosurg. 2022 Jan;157:e207-e214. doi: 10.1016/j.wneu.2021.09.130. Epub 2021 Oct 6.
8
Symptoms associated with malignancy of peripheral nerve sheath tumours: a retrospective study of 69 patients with neurofibromatosis 1.与外周神经鞘瘤恶性肿瘤相关的症状:对69例1型神经纤维瘤病患者的回顾性研究
Br J Dermatol. 2005 Jul;153(1):79-82. doi: 10.1111/j.1365-2133.2005.06558.x.
9
Expression of insulin-like growth-factor-1 receptor (IGF-1R) in peripheral nerve sheath tumors in neurofibromatosis type 1.胰岛素样生长因子-1受体(IGF-1R)在1型神经纤维瘤病外周神经鞘瘤中的表达
Anticancer Res. 2007 Jul-Aug;27(4A):2085-90.
10
Malignant peripheral nerve sheath tumors (MPNST) in NF1-affected children.患有1型神经纤维瘤病(NF1)的儿童中的恶性外周神经鞘瘤(MPNST)
Anticancer Res. 2007 Jul-Aug;27(4A):1957-60.

引用本文的文献

1
Surgical Measures Improving Functional Limitations of the Masticatory System, Aesthetic Deficits, and Skeletal Malformations in Neurofibromatosis Type 1-associated Hemifacial Diffuse Plexiform Neurofibroma Complicated by Rapidly Growing Midfacial Peripheral Nerve Sheath Tumor.手术措施改善1型神经纤维瘤病相关半侧面部弥漫性丛状神经纤维瘤合并快速生长的面中部周围神经鞘瘤所致咀嚼系统功能受限、美学缺陷和骨骼畸形
Cancer Diagn Progn. 2025 Sep 1;5(5):566-582. doi: 10.21873/cdp.10471. eCollection 2025 Sep-Oct.
2
Malignant Peripheral Nerve Sheath Tumor (MPNST) Arising from Orbital Plexiform Neurofibroma in a Small Child With Neurofibromatosis Type 1.1型神经纤维瘤病患儿眼眶丛状神经纤维瘤恶变形成的恶性外周神经鞘膜瘤
Cancer Diagn Progn. 2025 Mar 3;5(2):244-254. doi: 10.21873/cdp.10436. eCollection 2025 Mar-Apr.
3

本文引用的文献

1
International consensus statement on malignant peripheral nerve sheath tumors in neurofibromatosis.关于神经纤维瘤病中恶性外周神经鞘膜瘤的国际共识声明。
Cancer Res. 2002 Mar 1;62(5):1573-7.
2
NF1 mutations in neurofibromatosis 1 patients with plexiform neurofibromas.患有丛状神经纤维瘤的1型神经纤维瘤病患者中的NF1突变
Hum Mutat. 2002 Mar;19(3):309. doi: 10.1002/humu.9018.
3
Malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1: a clinicopathologic and molecular study of 17 patients.与1型神经纤维瘤病相关的恶性外周神经鞘瘤:17例患者的临床病理及分子研究
High-Grade Malignant Peripheral Nerve Sheath Tumor Arising From Common Peroneal Nerve Neurofibroma.源于腓总神经神经纤维瘤的高级别恶性外周神经鞘瘤。
Cureus. 2024 May 3;16(5):e59607. doi: 10.7759/cureus.59607. eCollection 2024 May.
4
Ultrasound-guided nerve block prior to biopsy of suspected neurogenic tumors: safety and feasibility in a pilot study.超声引导下神经阻滞活检疑似神经源性肿瘤:一项初步研究中的安全性和可行性。
Skeletal Radiol. 2023 Aug;52(8):1585-1590. doi: 10.1007/s00256-023-04306-7. Epub 2023 Feb 17.
5
A worldwide bibliometric analysis of malignant peripheral nerve sheath tumors from 2000 to 2022.2000年至2022年恶性外周神经鞘瘤的全球文献计量分析
Front Oncol. 2023 Jan 27;13:1111985. doi: 10.3389/fonc.2023.1111985. eCollection 2023.
6
Neurofibromatosis: New Clinical Challenges in the Era of COVID-19.神经纤维瘤病:COVID-19时代的新临床挑战
Biomedicines. 2022 Apr 19;10(5):940. doi: 10.3390/biomedicines10050940.
7
Malignant peripheral nerve sheath tumor: models, biology, and translation.恶性外周神经鞘瘤:模型、生物学和转化。
Oncogene. 2022 Apr;41(17):2405-2421. doi: 10.1038/s41388-022-02290-1. Epub 2022 Apr 7.
8
Neurofibromin and suppression of tumorigenesis: beyond the GAP.神经纤维瘤病和抑瘤作用:不仅仅是 GAP。
Oncogene. 2022 Feb;41(9):1235-1251. doi: 10.1038/s41388-021-02156-y. Epub 2022 Jan 23.
9
Surgery for Peripheral Nerve Sheath Tumours of the Buttocks, Legs and Feet in 90 Patients With Neurofibromatosis Type 1.90例1型神经纤维瘤病患者臀部、腿部和足部周围神经鞘瘤的手术治疗
In Vivo. 2021 Mar-Apr;35(2):889-905. doi: 10.21873/invivo.12329.
10
New insights into the neurofibroma tumor cells of origin.对神经纤维瘤肿瘤起源细胞的新见解。
Neurooncol Adv. 2019 Nov 10;2(Suppl 1):i13-i22. doi: 10.1093/noajnl/vdz044. eCollection 2020 Jul.
Arch Dermatol. 2001 Jul;137(7):908-13.
4
Mortality in neurofibromatosis 1: an analysis using U.S. death certificates.1型神经纤维瘤病的死亡率:一项基于美国死亡证明的分析
Am J Hum Genet. 2001 May;68(5):1110-8. doi: 10.1086/320121. Epub 2001 Mar 28.
5
Malignant peripheral nerve sheath tumors in neurofibromatosis 1.1型神经纤维瘤病中的恶性外周神经鞘瘤
Am J Med Genet. 2000 Aug 28;93(5):388-92.
6
A clinical study of type 1 neurofibromatosis in north west England.英格兰西北部1型神经纤维瘤病的临床研究。
J Med Genet. 1999 Mar;36(3):197-203.
7
Malignant peripheral nerve sheath tumor: analysis of treatment outcome.恶性外周神经鞘膜瘤:治疗结果分析
Int J Radiat Oncol Biol Phys. 1998 Sep 1;42(2):351-60. doi: 10.1016/s0360-3016(98)00223-5.
8
CT imaging in adults with neurofibromatosis-1: frequent asymptomatic plexiform lesions.1型神经纤维瘤病成人患者的CT成像:频繁出现无症状的丛状病变。
Neurology. 1998 Jun;50(6):1755-60. doi: 10.1212/wnl.50.6.1755.
9
MR imaging differentiation of benign and malignant peripheral nerve sheath tumors: use of the target sign.良性与恶性周围神经鞘瘤的磁共振成像鉴别:靶征的应用
Pediatr Radiol. 1997 Feb;27(2):124-9. doi: 10.1007/s002470050082.
10
Von Recklinghausen neurofibromatosis. A clinical and population study in south-east Wales.冯·雷克林霍增氏神经纤维瘤病。威尔士东南部的一项临床与人群研究。
Brain. 1988 Dec;111 ( Pt 6):1355-81. doi: 10.1093/brain/111.6.1355.